Fairvalue-Calculator Fairvalue-Calculator
EN DE

Genic Co (123330) Fair Value & Analysis

Consumer Defensive · KR · Market cap 174B KRW

Price20,100 KRW
Fair Value28,853 KRW
Upside+43.5%
Quality95/100
Evidence: High Range 21,639 KRW – 36,066 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Genic Co (123330) currently trades at 20,100 KRW, while our model-based Fair Value estimate is 28,853 KRW — implying the stock looks roughly 43.5% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; and shampoo and tonic. It offers its products under the CELEDERMA, CELEDERMA daily, and Excuse my Frank brands. Genic Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Genic Co (123330) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 28,853 KRW versus a price of 20,100 KRW — about +44% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 123330?
Our 21-model fair value for Genic Co is 28,853 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 20,100 KRW.
What is the quality score of 123330?
Genic Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.